Role of macrophages and inflammatory mediators in chemically induced toxicity

被引:123
作者
Laskin, DL
Laskin, JD
机构
[1] Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA
关键词
macrophages; inflammatory mediators toxicity;
D O I
10.1016/S0300-483X(00)00437-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Macrophages are critical cellular effecters of nonspecific host defense. They are also potent secretory cells releasing an array of mediators including proinflammatory and cytotoxic cytokines and growth factors, bioactive lipids, hydrolytic enzymes and reactive oxygen and nitrogen intermediates, each of which has been implicated in tissue injury. The research in our laboratories has focused on analyzing the role of macrophages in chemically induced injury in the lung and the liver. In both these tissues, a localized accumulation of macrophages is observed following toxicant exposure. This is directly correlated with the generation of cytotoxic inflammatory mediators at these sites. Moreover, when macrophage functioning is blocked, pulmonary and hepatic injury induced by toxicants such as ozone or acetaminophen is prevented. These findings provide direct support for our hypothesis that macrophages contribute to tissue injury. Approaches using pharmacologic inhibitors and transgenic animals are currently being used to evaluate the specific macrophage-derived products involved in the pathogenic process. Our results suggest that the extent to which a particular mediator contributes to injury depends on the nature of the toxicant, the target tissue, and quantities of the mediator produced. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:111 / 118
页数:8
相关论文
共 59 条
  • [1] THE CELL BIOLOGY OF MACROPHAGE ACTIVATION
    ADAMS, DO
    HAMILTON, TA
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1984, 2 : 283 - 318
  • [2] PATHOLOGICAL IMPLICATIONS OF NITRIC-OXIDE, SUPEROXIDE AND PEROXYNITRITE FORMATION
    BECKMAN, JS
    CROW, JP
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1993, 21 (02) : 330 - 334
  • [3] BEUTLER B, 1987, NEW ENGL J MED, V316, P379
  • [4] Douni E, 1996, J INFLAMM, V47, P27
  • [5] Fakhrzadeh L, 1999, AM J RESP CRIT CARE, V159, pA272
  • [6] FAKHRZADEH L, 2001, IN PRESS AM J RESP C
  • [7] FAKHRZADEH L, 2000, AM J RESP CRIT CARE, V161, pA30
  • [8] FAKHRZADEH L, 1999, TOXICOL SCI, V48, P200
  • [9] Franková D, 1998, EUR J IMMUNOL, V28, P838, DOI 10.1002/(SICI)1521-4141(199803)28:03<838::AID-IMMU838>3.3.CO
  • [10] 2-K